Last reviewed · How we verify
AZD1940
At a glance
| Generic name | AZD1940 |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940 (PHASE2)
- Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AZD1940 CI brief — competitive landscape report
- AZD1940 updates RSS · CI watch RSS
- AstraZeneca portfolio CI